With a portfolio spanning multiple products and focus areas, we are positioned for market leadership and ready to meet growing global demand. 

Our leadership team brings proven experience and credibility, having built and exited multi-billion-dollar businesses and led innovation on a global stage. That expertise shapes how we think, build and deliver. 

Our integrated capabilities, from reagent production to printed electronics, ensure resilient supply chains and cost-effective scale. With regulatory milestones achieved, clinical trials advancing and manufacturing ready to expand, Sapphiros is entering a new phase of commercial readiness. We are uniquely positioned to lead a growing market that connects consumer health, clinical diagnostics and preventive care. 

Sapphiros’ purpose is clear: to shape the future of decentralised and accessible testing through innovation that puts people first. We see a world where testing is not confined to laboratories or clinics but becomes part of everyday life. 

Roche announcement 

(Press release details TBC) This partnership strengthens our position as a trusted pioneer in connected diagnostics, combining Sapphiros innovation with Roche’s global expertise and reach. 

Together, we are advancing a shared vision to make high-quality testing accessible to everyone, everywhere.  

Reporting 
(Details TBC) 

Guiding principles and sustainability 

At Sapphiros, sustainability is central to our purpose. We are building a testing ecosystem that delivers both commercial success and social responsibility. 

Our innovations improve access to healthcare everywhere, ensuring that progress in diagnostics benefits all communities. We design technologies that perform equally well in advanced healthcare systems and resource-limited environments. 

Our sustainability approach focuses on three principles: 

• Equity of access – making health available to everyone

• Responsible manufacturing – using automation, printed electronics and scalable production to reduce waste and environmental impact

• Global readiness – maintaining control of our supply chain to respond quickly and effectively in health emergencies 

By aligning purpose with science, Sapphiros shows that affordable innovation can create meaningful, lasting change. 

Investor information 

Sapphiros is supported by a strong commercial pipeline and trusted global partnerships, including the Gates Foundation, Roche and the US government. 

We are growing in a market shaped by self-testing, connected diagnostics and preventive care. Our dual-market model, serving both healthcare professionals and consumers, creates opportunities for sustainable scale and long-term value. 

Key highlights:

• Strong regulatory and clinical progress across multiple products

• Extreme Volume Manufacturing (EVM) capacity exceeding five billion units each year

• Proven scientific leadership with a track record of global success

• Clear path to profitability through scalable technology and diversified markets 

Sapphiros is more than a diagnostics company. It represents a movement towards a healthier, more connected world, powered by science, designed for people and ready to scale.